Lv6
2435 积分 2022-04-04 加入
ACR Appropriateness Criteria Acute Trauma to the Knee
3天前
已完结
Incidence and survival of neuroendocrine neoplasms in China with comparison to the United States
5天前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
15天前
已完结
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
15天前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
15天前
已完结
Global prevalence of ankylosing spondylitis
15天前
已完结
[Recommendations for diagnosis and treatment of ankylosing spondylitis]
15天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
15天前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
15天前
已完结
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non–Small Cell Lung Cancer With No Actionable Gene Alterations
19天前
已完结
皖公网安备34019202002308
